Business Of Biotech
An Unanticipated Biotech Startup With OS Therapies' Paul Romness
Nov 4, 2024
Paul Romness, CEO and Chair of OS Therapies, shares his unexpected journey into biotech, sparked by his daughter's best friend's battle with osteosarcoma. He discusses how personal challenges led to the creation of a company focused on innovative cancer treatments. The podcast highlights Olivia's inspiring progression to med school while serving on the board, and examines the importance of community and strategic networking in shaping the startup's mission. Romness reflects on navigating career transitions and aspirations for advancing pediatric cancer treatment.
49:12
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Paul Romness transitioned from a career in big biotech to founding OS Therapies, motivated by his daughter's best friend's battle with osteosarcoma.
- OS Therapies is developing innovative antibody drug conjugates aimed at improving treatment options for osteosarcoma and potentially other solid tumors.
Deep dives
Olivia Egge's Inspirational Journey
The story of Olivia Egge, diagnosed with osteosarcoma, serves as a pivotal inspiration behind the creation of OS Therapies. As the daughter of a neighbor and a close friend of Paul Romness's daughter, Olivia's battle with the deadly bone cancer deeply impacted Romness, motivating him to take action. Remarkably, Olivia has overcome her diagnosis and is now seven years cancer-free, currently pursuing her medical studies. This success story highlights both the personal ties to the disease and the urgency felt by Romness and others to change the course of treatment options for osteosarcoma.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
